1eye wrote:While they might just be fronts for the nay-sayers, I think the Cochrane review is highly regarded, and it is unlikely that they would be interested in meta-analysis of things anyone seriously thinks don't exist. I suppose anything is possible but I doubt it.
There is currently no high level evidence to support or refute the efficacy or safety of percutaneous transluminal angioplasty for treatment of CCSVI in people with MS. Clinical practice should be guided by evidence supported by well-designed randomised controlled trials: closure of some of the gaps in the evidence may be feasible at the time of completion of the six ongoing clinical trials.
Our searches retrieved 159 references, six of which were to ongoing trials. Based on assessment of the title or abstract, or both, we excluded all of the studies, with the exception of one which was evaluated following examination of the full text report. However, this study also did not meet our inclusion criteria and was subsequently excluded.
Users browsing this forum: Robnl